SILEXION THERAPEUTICS CORP
Q3 2025 13F Holders
Symbol
SLXN
CUSIP
G1281K130
Type
Equity
Class
ORD SHS NEW
Num filers
4
Total reported value, excl. options
$17.3 k
Compare 2025 Q3 to
2026 Q1
2025 Q4
2025 Q2
Manager
Report Date
Value ($000)
Shares
Option Type